Alimera Sciences to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
Rhea-AI Summary
Alimera Sciences (Nasdaq: ALIM), a global pharmaceutical firm focused on retinal health, announced that CEO Rick Eiswirth will present at the HC Wainwright 2nd Annual Ophthalmology Conference on August 17, 2022. The presentation will be available on demand starting at 7:00 AM ET. Additionally, Alimera's management will hold one-on-one meetings with registered investors during the conference. This engagement highlights Alimera's commitment to enhancing vision care and its ongoing relationship with the investment community.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ALIM gained 2.06%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will deliver a corporate presentation at the HC Wainwright 2nd Annual Ophthalmology Conference being held virtually on Wednesday, August 17, 2022.
The presentation will be available on demand at 7:00am ET on August 17, 2022. In addition to the presentation, management will be available for one-on-one meetings with investors who are registered to attend the conference.
Register here: https://hcwevents.com/ophthalmologyconference/
About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com | For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
FAQ
When will Alimera Sciences present at the HC Wainwright 2nd Annual Ophthalmology Conference?
Who is delivering the presentation for Alimera Sciences at the conference?
Will there be any opportunities for investors to meet with Alimera Sciences' management?
How can I access the Alimera Sciences presentation?
What is the stock symbol for Alimera Sciences?
